ArticleScientific reports2026

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat EMT6 cell line-derived triple-negative breast cancer.

Stephanie C Pero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.